Formulation Development & Screening
At Helix Biotech, we've developed our own manufacturing platform to quickly and reliably screen nanoparticle formulations, such as lipid nanoparticles (LNP), liposomes, emulsions, and polymer-based particles.
Selecting the Right Nanoparticle Formulation
Our team of scientists select from a library of well known and novel lipid- or polymer-based formulations, sourced from our partners and suppliers, to optimize the encapsulation, targeted delivery, and expression of your API.
Optimization by Design of Experiments (DOE) - Our experts apply the Design of Experiments concept to help optimize your formulation, improve your delivery system and therapeutics, and accelerate your project success.
We help identify key variables that have the greatest impact on formulation stability and efficacy, and determine the optimal parameters to achieve your goals.
Leadtimes as low as 2 weeks
How we decrease LNP leadtimes
1) We synthesize and acquire high quality mRNA and lipid reagents to lower acquisition time.
2) We've innovated automated manufacturing platform (i.e. the Nova™ IJM) to streamline nanoparticle production for a wide sample volume range (microliter to liter scale).
3) Our highly experienced and educated team has decades of liposome, LNP, and manufacturing experience.